BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15008996)

  • 1. Effects of conjugated oestrogen and droloxifene on the renin-angiotensin system, blood pressure and renal blood flow in postmenopausal women.
    Seely EW; Brosnihan KB; Jeunemaitre X; Okamura K; Williams GH; Hollenberg NK; Herrington DM
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):315-21. PubMed ID: 15008996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys.
    Brosnihan KB; Weddle D; Anthony MS; Heise C; Li P; Ferrario CM
    J Hypertens; 1997 Jul; 15(7):719-26. PubMed ID: 9222939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response effect of conjugated equine oestrogen on blood pressure in postmenopausal women with hypertension.
    Harvey PJ; Molloy D; Upton J; Wing LM
    Blood Press; 2000; 9(5):275-82. PubMed ID: 11193131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women.
    Harvey PJ; Wing LM; Savage J; Molloy D
    J Hypertens; 1999 Mar; 17(3):405-11. PubMed ID: 10100079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of droloxifene and estrogen on thyroid function in postmenopausal women.
    Marqusee E; Braverman LE; Lawrence JE; Carroll JS; Seely EW
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4407-10. PubMed ID: 11095487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with Standard and Low Dose of Conjugated Equine Estrogen Differentially Modulates Estrogen Receptor Expression and Response to Angiotensin II in Mesenteric Venular Bed of Surgically Postmenopausal Hypertensive Rats.
    Araujo PX; Costa TJ; Echem C; Aparecida de Oliveira M; Santos-Eichler RA; Colli LG; Jiménez-Altayó F; Vila E; Akamine EH; Dantas AP; Ceravolo GS; de Carvalho MHC
    J Pharmacol Exp Ther; 2017 Jul; 362(1):98-107. PubMed ID: 28533289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of raloxifene on the renin-angiotensin-aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Takahashi T; Kumakura H; Takayama Y; Kanda T; Murakami M; Kurabayashi M
    Geriatr Gerontol Int; 2010 Jan; 10(1):70-7. PubMed ID: 20102385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women.
    Herrington DM; Pusser BE; Riley WA; Thuren TY; Brosnihan KB; Brinton EA; MacLean DB
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1606-12. PubMed ID: 10845879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
    Brown NJ; Abbas A; Byrne D; Schoenhard JA; Vaughan DE
    Circulation; 2002 Jan; 105(3):304-9. PubMed ID: 11804984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hormone therapy on blood pressure and the renin-angiotensin system in postmenopausal women.
    Prime DD; Brosnihan KB; Herrington DM
    Minerva Cardioangiol; 2007 Aug; 55(4):477-85. PubMed ID: 17653023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
    Sumino H; Ichikawa S; Miya Y; Sakamaki T; Kurabayashi M
    Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women.
    Schunkert H; Danser AH; Hense HW; Derkx FH; Kürzinger S; Riegger GA
    Circulation; 1997 Jan; 95(1):39-45. PubMed ID: 8994414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women.
    Umeda M; Ichikawa S; Kanda T; Sumino H; Kobayashi I
    Am J Hypertens; 2001 Mar; 14(3):206-11. PubMed ID: 11281230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
    Ichikawa A; Sumino H; Ogawa T; Ichikawa S; Nitta K
    Geriatr Gerontol Int; 2008 Dec; 8(4):259-64. PubMed ID: 19149837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of gender on the renal response to angiotensin II.
    Miller JA; Anacta LA; Cattran DC
    Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J; Wuerzner G; Jensen C; Brunner HR
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.